Every insight for bio investing, in one app
Clinical trial progress, FDA approvals, M&A news, earnings calendars—Buybio delivers everything a bio/pharma investor needs in real time, across iOS, Android, and Web.
Built for Global Bio Investors
Languages: Korean, English, German, Japanese, Chinese
Platforms: iOS, Android, and Web — fully in sync
Real-time updates for clinical, FDA, M&A, and earnings data
Three Powerful Tabs
From market-wide overview in Home to deep R&D intelligence in Bio—everything you need to invest with confidence.
Home — Market Overview
Market Overview & Heatmap
Scan the entire bio market at a glance with a sector heatmap. Theme and sector analysis tables, real-time indices, and curated watch lists keep you oriented every trading day.
- Sector heatmap for instant market visualization
- Theme and sector analysis table
- Real-time key bio index tracking
- Market momentum scorecard
- Curated top movers and stocks to watch
- Quick search by ticker or company name
Finance — Core Investment Data
Stocks, M&A & Earnings Calendar
Discover investment candidates with the bio stock screener, capture event-driven opportunities with M&A news and the Earnings Calendar (calendar and list views), and analyze competition directly from the stock detail screen.
- Bio & pharma-specific stock screener
- Real-time M&A deal news feed
- Earnings Calendar (calendar and list views)
- Stock detail screen with competition analysis
- Watchlist and portfolio tracking
- Price alerts and event notifications
Bio — Deep R&D Intelligence
Clinical Trials, FDA & Patents
Track clinical trial progress by phase, disease, and company. Monitor this month's FDA approvals, search the patent registry, and follow key research publications—so your investment thesis is grounded in science.
- Clinical trial tracking (Phase 1–3, by disease and company)
- FDA approvals this month
- Patent registry search
- Research publication feed (PubMed integration)
- Pipeline progress visualization
- Regulatory event schedule alerts
Wherever you are, seamlessly
Android
Coming soon to Google Play. Stay tuned!
Coming SoonWeb
Web version coming soon. Stay tuned!
Coming SoonFrequently Asked Questions
Q.Who is Buybio designed for?
Buybio is for both individual and professional investors interested in the bio/pharma sector. Beginners can start with the Home tab's heatmap and market overview, while experienced investors can dive deep into clinical trial data, FDA approvals, and the professional stock screener.
Q.What languages does Buybio support?
Buybio supports five languages: Korean, English, German, Japanese, and Chinese. You can switch languages in the app settings, and the entire interface will update to your selected language.
Q.Where does the clinical trial data come from?
Clinical trial data is sourced from authoritative global databases including ClinicalTrials.gov. FDA approval data is sourced directly from the FDA's official database and updated in real time.
Q.When will the Android and web versions launch?
The Android app and web version are currently in development and coming soon. In the meantime, try Buybio on the iOS App Store!
Q.Is Buybio free to use?
Core features are free. Premium features—including advanced screeners, unlimited alerts, and in-depth pipeline analytics—are available via a paid subscription. Check the plans inside the app.
Start investing smarter today
Download on the App Store right now. Every bio investing insight you need, right in your pocket.